New review shows statins remain first-line therapy in MASLD, while PCSK9 inhibitors offer potential but require more evidence. Learn more about evolving treatment guidance.

Millions of Americans take statins daily to manage their cholesterol levels and reduce heart disease risk. These medications have long been considered workhorses in cardiovascular care, but new ...

Dr. Granger answers the question: 'Are Side Effects With Statins Common?' — -- Question: My doctor just put me on a statin. I understand it helps lower cholesterol, but I am worried about ...

Results inconsistent for association with bile acid sequestrant use depending on diabetes and liver disease status. HealthDay News — The use of cholesterol absorption inhibitors is associated with a ...

Share on Pinterest Scientists have found a link between cholesterol absorption inhibitors and liver cancer. Sergii Kolesnikov/Getty Images Out of five non-statin cholesterol-lowering drug classes, ...

A recent breakthrough study has uncovered a promising link between non-statin cholesterol-lowering medications and liver cancer prevention. Among the drugs examined, ezetimibe—commonly known by its ...

Past studies have suggested that taking cholesterol-lowering statin drugs may lower individuals' risk of developing liver cancer. In a new study of non-statin cholesterol-lowering medications, one ...

O nce upon a time, cholesterol was simple. This molecule, it was proclaimed, came in two varieties: an artery-clogging “bad” ...